Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Arpita S. Pal"'
Autor:
Wenqing Zhou, Arpita S. Pal, Alan Yi-Hui Hsu, Theodore Gurol, Xiaoguang Zhu, Sara E. Wirbisky-Hershberger, Jennifer L. Freeman, Andrea L. Kasinski, Qing Deng
Publikováno v:
Cell Reports, Vol 22, Iss 7, Pp 1810-1823 (2018)
Summary: MicroRNA-223 is known as a myeloid-enriched anti-inflammatory microRNA that is dysregulated in numerous inflammatory conditions. Here, we report that neutrophilic inflammation (wound response) is augmented in miR-223-deficient zebrafish, due
Externí odkaz:
https://doaj.org/article/9d70290089e5477382636bef5709fc6a
Autor:
Andrea L. Kasinski, Kayla Gates, Jenna Clingerman, Chennan Li, Manvir Bains, Ikjot Singh Sohal, Jihye Son, Nadia A. Lanman, Alejandra Agredo, Arpita S. Pal
Supplementary Data from Loss of KMT5C Promotes EGFR Inhibitor Resistance in NSCLC via LINC01510-Mediated Upregulation of MET
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b9e9f80eb4de886d06698dd39359a55b
https://doi.org/10.1158/0008-5472.22429852
https://doi.org/10.1158/0008-5472.22429852
Autor:
Andrea L. Kasinski, Kayla Gates, Jenna Clingerman, Chennan Li, Manvir Bains, Ikjot Singh Sohal, Jihye Son, Nadia A. Lanman, Alejandra Agredo, Arpita S. Pal
EGFR inhibitors (EGFRi) are standard-of-care treatments administered to patients with non–small cell lung cancer (NSCLC) that harbor EGFR alterations. However, development of resistance posttreatment remains a major challenge. Multiple mechanisms c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::12538522dd78c2343de44d0c9a2a2429
https://doi.org/10.1158/0008-5472.c.6513478.v1
https://doi.org/10.1158/0008-5472.c.6513478.v1
Loss of KMT5C Promotes EGFR Inhibitor Resistance in NSCLC via LINC01510-Mediated Upregulation of MET
Autor:
Arpita S. Pal, Alejandra Agredo, Nadia A. Lanman, Jihye Son, Ikjot Singh Sohal, Manvir Bains, Chennan Li, Jenna Clingerman, Kayla Gates, Andrea L. Kasinski
Publikováno v:
Cancer Res
EGFR inhibitors (EGFRi) are standard-of-care treatments administered to patients with non–small cell lung cancer (NSCLC) that harbor EGFR alterations. However, development of resistance posttreatment remains a major challenge. Multiple mechanisms c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ac077bdc683d5ccc1c3514d40cecd022
https://doi.org/10.1158/0008-5472.can-20-0821
https://doi.org/10.1158/0008-5472.can-20-0821
Epidermal growth factor receptor inhibitors (EGFRi) are standard-of-care treatments administered to patients with non-small cell lung cancer (NSCLC) that harbor EGFR alterations. However, development of resistance within a year post-treatment remains
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1d7b5cc92aa7032e94c1f1c175011335
https://doi.org/10.1101/2020.03.17.995951
https://doi.org/10.1101/2020.03.17.995951
Publikováno v:
Biochemical pharmacology
Lung cancer is the leading cause of cancer-related deaths, demanding improvement in current treatment modalities to reduce the mortality rates. Lung cancer is divided into two major classes with non-small cell lung cancer representing ~84% of lung ca
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::39b3ec66405a8c46f84d281c90a8141f
http://europepmc.org/articles/PMC7854807
http://europepmc.org/articles/PMC7854807
Autor:
Qing Deng, Arpita S. Pal, Andrea L. Kasinski, Xiaoguang Zhu, Theodore Gurol, Wenqing Zhou, Sara E. Wirbisky-Hershberger, Jennifer L. Freeman, Alan Y. Hsu
Publikováno v:
Department of Biological Sciences Faculty Publications
Cell Reports, Vol 22, Iss 7, Pp 1810-1823 (2018)
Cell reports
Cell Reports, Vol 22, Iss 7, Pp 1810-1823 (2018)
Cell reports
SUMMARY MicroRNA-223 is known as a myeloid-enriched anti-inflammatory microRNA that is dysregulated in numerous inflammatory conditions. Here, we report that neutrophilic inflammation (wound response) is augmented in miR-223-deficient zebrafish, due
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::be1bb5c09ffbbd5c4e1d7693355732d6
https://docs.lib.purdue.edu/bioscipubs/84
https://docs.lib.purdue.edu/bioscipubs/84
Autor:
Andrea L. Kasinski, Alan Y. Hsu, Arpita S. Pal, Sarah E. Wirbisky, Theodore Gurol, Wenqing Zhou, Jennifer L. Freeman, Xiaoguang Zhu, Qing Deng
Publikováno v:
SSRN Electronic Journal.
MicroRNA‐223, a principally myeloid‐specific anti‐inflammatory microRNA, is dysregulated in numerous inflammatory conditions. Here we report that miR223 deficient zebrafish displayed augmented neutrophilic inflammation, which was due primarily
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e54f14526a2bb2ab39bbed0652848387
https://doi.org/10.2139/ssrn.3155596
https://doi.org/10.2139/ssrn.3155596
Autor:
Andrea L. Kasinski, Arpita S. Pal
The discovery of the microRNAs, lin-4 and let-7 as critical mediators of normal development in Caenorhabditis elegans and their conservation throughout evolution has spearheaded research towards identifying novel roles of microRNAs in other cellular
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::594e6ac8971c0447f9db5b20d13379de
https://doi.org/10.1016/bs.acr.2017.06.006
https://doi.org/10.1016/bs.acr.2017.06.006
Publikováno v:
Cancer Research. 77:3142-3142
Lung cancer is the leading cause of cancer-related deaths in the world. Non-small cell lung cancer (NSCLC) accounts for ~85% of the cases. NSCLC patients frequently harbor causal gene mutations. Epidermal Growth Factor Receptor (EGFR), an NSCLC causa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::db40ff27f1fbd14a2f6e59620b0145d1
https://doi.org/10.1158/1538-7445.am2017-3142
https://doi.org/10.1158/1538-7445.am2017-3142